Publication | Closed Access

Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

UrologySurgical OncologyGenitourinary CancerMedicinePharmacotherapySurgerySafety ResultsCancer TreatmentOncologyAbacus TrialNeoadjuvant Atezolizumab